Here's the live share price of Cohance Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cohance Lifesciences | -2.26 | 3.64 | 12.70 | 5.85 | -59.62 | -3.24 | -0.97 |
| Sun Pharmaceutical Industries | -0.11 | 6.22 | 15.40 | 15.51 | 13.49 | 21.51 | 22.92 |
| Divi's Laboratories | 6.18 | 8.98 | 16.52 | 18.19 | 6.97 | 25.63 | 8.62 |
| Torrent Pharmaceuticals | -2.79 | 7.15 | 14.06 | 16.52 | 36.02 | 34.91 | 26.26 |
| Zydus Lifesciences | -0.67 | 7.65 | 21.24 | 29.70 | 16.37 | 23.81 | 12.31 |
| Cipla | -1.41 | 5.01 | 14.54 | 1.96 | -4.32 | 11.17 | 7.81 |
| Lupin | -2.19 | 7.71 | 5.04 | 12.09 | 24.86 | 37.76 | 15.55 |
| Mankind Pharma | -1.32 | 5.41 | 17.34 | 17.64 | -5.65 | 10.55 | 11.84 |
| Dr. Reddy's Laboratories | -2.78 | -4.58 | -1.99 | 3.81 | -4.15 | 4.99 | 2.24 |
| Aurobindo Pharma | -1.89 | 7.95 | 10.79 | 31.52 | 33.03 | 27.70 | 9.73 |
| Laurus Labs | -0.56 | 11.74 | 34.77 | 43.97 | 86.19 | 63.28 | 18.14 |
| Biocon | 4.43 | 6.15 | 22.00 | 16.22 | 10.12 | 18.15 | 1.23 |
| Alkem Laboratories | -2.16 | 3.74 | -0.66 | -3.39 | 10.63 | 15.21 | 9.98 |
| Glenmark Pharmaceuticals | -2.03 | 4.71 | -0.53 | 12.32 | 0.42 | 47.13 | 26.81 |
| Abbott India | 3.28 | 7.95 | 8.59 | 0.86 | -17.92 | 6.56 | 10.08 |
| Ipca Laboratories | 7.35 | 24.75 | 30.72 | 28.95 | 30.17 | 34.61 | 12.63 |
| Anthem Biosciences | 3.33 | 1.58 | 8.29 | 26.81 | 6.78 | 2.21 | 1.32 |
| Ajanta Pharma | 1.87 | 10.71 | 22.36 | 27.01 | 22.41 | 33.54 | 19.08 |
| GlaxoSmithKline Pharmaceuticals | 1.01 | 11.88 | 0.33 | 5.60 | -22.40 | 20.18 | 8.89 |
| Gland Pharma | -1.20 | 11.50 | 36.42 | 45.95 | 22.00 | 27.87 | -8.69 |
Source: Dion Global
Over the last one year, Cohance Lifesciences has declined 59.62% compared to peers like Sun Pharmaceutical Industries (13.49%), Divi's Laboratories (6.97%), Torrent Pharmaceuticals (36.02%). From a 5 year perspective, Cohance Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (22.92%) and Divi's Laboratories (8.62%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 443.38 | 441.29 |
| 10 | 444.96 | 443 |
| 20 | 441.82 | 441.61 |
| 50 | 440.35 | 430.66 |
| 100 | 386.27 | 436.43 |
| 200 | 497.47 | 521.93 |
Source: Dion Global
In the latest quarter, Cohance Lifesciences remained same as its previous close in promoter holding, while DII stake increased to 21.79%, FII holding fell to 5.59%, and public shareholding moved up to 15.11% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 62,66,199 | 4.31 | 285.83 | |
| 52,00,000 | 1.23 | 237.2 | |
| 41,43,548 | 0.18 | 189.01 | |
| 40,13,973 | 0.92 | 183.1 | |
| 32,85,254 | 0.9 | 149.86 | |
| 31,79,881 | 4.13 | 145.05 | |
| 30,00,000 | 0.33 | 136.85 | |
| 28,08,197 | 1.08 | 128.1 | |
| 27,62,648 | 0.7 | 126.02 | |
| 27,25,813 | 0.44 | 124.34 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Jul 08, 2026, 12:46 AM IST IST | Cohance Lifesciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jun 24, 2026, 09:37 PM IST IST | Cohance Lifesciences - Clarification On Volume Movement |
| Jun 24, 2026, 08:03 PM IST IST | Cohance Lifesciences - Clarification sought from Cohance Lifesciences Ltd |
| Jun 18, 2026, 09:13 PM IST IST | Cohance Lifesciences - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regu |
| Jun 18, 2026, 04:03 AM IST IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Resignation of Director |
Source: Dion Global
Cohance Lifesciences Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 2030.50 Cr. and Equity Capital is Rs. 38.26 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cohance Lifesciences is ₹441.35 as on Jul 17, 2026.
The Cohance Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Cohance Lifesciences is ₹16,884.60 Cr as on Jul 17, 2026.
Today’s highest and lowest price of Cohance Lifesciences are ₹471.45 and ₹431.05.
The 52-week high/low is the highest and lowest price at which Cohance Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Cohance Lifesciences is ₹1,121.15 and 52-week low of Cohance Lifesciences is ₹267.85 as on Jul 17, 2026.
The Cohance Lifesciences has shown returns of -0.3% over the past day, 3.64% for the past month, 12.7% over 3 months, -59.62% over 1 year, -3.24% across 3 years, and -0.97% over 5 years.
P/E ratio of and PB ratio of Cohance Lifesciences are 94.21 and 4.32 on Jul 17, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global